% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • wilderguide wilderguide Aug 2, 2013 9:22 PM Flag

    Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells

    Pubished May 2013, Yamagichi et BMC
    Current research on tumor escape and treatment resistance with chronic VEGF inhibition.
    Further evidence that concurrent MET inhibition may mitigate long-term VEGF inhibition therapy.
    Good read...

4.61+0.07(+1.54%)Apr 29 4:00 PMEDT